Evaluation of the effect of Pistacia atlantica on fasting blood sugar in patients with type 2 diabetes

Phase 3

Conditions: Diabetes mellitus.
Diabetes mellitus due to underlying condition

Registration Number: IRCT20161031030616N2

Lead Sponsor: Gorgan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: All

Target Recruitment: 42

Inclusion Criteria

The patient's desire to enter the study
Age between 30-64 years, whose definitive diagnosis of diabetes has been made by performing two FBS tests more than 126 and the approval of the relevant specialist.
Patients with a history of type 2 diabetes are diagnosed less than two years after the onset of the disease and use at least one standard oral medication (metformin tablets) for initial control of the disease.
HbA1c is more equal to 8% and less than 9%.

Exclusion Criteria

blood sugar more than 300 and HbA1c is more equal to 9% .
Have indications for starting insulin and other injectable therapy.
Patients treated with insulin
Moderate to severe renal insufficiency (GFR less than 45 or albuminuria more than 300 mg)
Liver failure (diagnosis by an internal medicine specialist or gastroenterologist based on bilirubin, albumin and liver enzymes)
Class 3 and 4 heart failure
Diabetic retinopathy
Serious medical illness
Simultaneous infectious diseases including pulmonary tuberculosis, diabetic foot ulcers and ...
High blood pressure (systolic above 160 or diastolic above 100 mm Hg) or need to take more than three antihypertensive drugs
Women who decide to get pregnant
Pregnant women and lactating women

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
FBS. Timepoint: At the beginning of the study (before the intervention) and At the end of three months from the start of the intervention. Method of measurement: Calorimetric by enzymatic method.;Two-hour blood sugar. Timepoint: At the beginning of the study (before the intervention) and At the end of three months from the start of the intervention. Method of measurement: Calorimetric by enzymatic method.;HbA?C. Timepoint: At the beginning of the study (before the intervention) and At the end of three months from the start of the intervention. Method of measurement: chromatography.

Secondary Outcome Measures